Effect of Macitentan on Long-term Outcomes in Patients With Pulmonary Arterial Hypertension (PAH): Subanalysis of SERAPHIN Comparing Incident and Prevalent Patient Populations Not Treated With Background PAH-Specific Therapy
Publication
, Journal Article
Simonneau, G; Channick, R; Delcroix, M; Galiè, N; Ghofrani, H; Jansa, P; Le Brun, F-O; Mehta, S; Perchenet, L; Pulido, T; Sastry, B; Sitbon, O ...
Published in: Chest
October 2013
Duke Scholars
Published In
Chest
DOI
ISSN
0012-3692
Publication Date
October 2013
Volume
144
Issue
4
Start / End Page
876A / 876A
Publisher
Elsevier BV
Related Subject Headings
- Respiratory System
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Simonneau, G., Channick, R., Delcroix, M., Galiè, N., Ghofrani, H., Jansa, P., … Rubin, L. (2013). Effect of Macitentan on Long-term Outcomes in Patients With Pulmonary Arterial Hypertension (PAH): Subanalysis of SERAPHIN Comparing Incident and Prevalent Patient Populations Not Treated With Background PAH-Specific Therapy. Chest, 144(4), 876A-876A. https://doi.org/10.1378/chest.1701395
Simonneau, Gùrald, Richard Channick, Marion Delcroix, Nazzareno Galiè, Hossein Ghofrani, Pavel Jansa, Franck-Olivier Le Brun, et al. “Effect of Macitentan on Long-term Outcomes in Patients With Pulmonary Arterial Hypertension (PAH): Subanalysis of SERAPHIN Comparing Incident and Prevalent Patient Populations Not Treated With Background PAH-Specific Therapy.” Chest 144, no. 4 (October 2013): 876A-876A. https://doi.org/10.1378/chest.1701395.
Simonneau G, Channick R, Delcroix M, Galiè N, Ghofrani H, Jansa P, et al. Effect of Macitentan on Long-term Outcomes in Patients With Pulmonary Arterial Hypertension (PAH): Subanalysis of SERAPHIN Comparing Incident and Prevalent Patient Populations Not Treated With Background PAH-Specific Therapy. Chest. 2013 Oct;144(4):876A-876A.
Simonneau, Gùrald, et al. “Effect of Macitentan on Long-term Outcomes in Patients With Pulmonary Arterial Hypertension (PAH): Subanalysis of SERAPHIN Comparing Incident and Prevalent Patient Populations Not Treated With Background PAH-Specific Therapy.” Chest, vol. 144, no. 4, Elsevier BV, Oct. 2013, pp. 876A-876A. Crossref, doi:10.1378/chest.1701395.
Simonneau G, Channick R, Delcroix M, Galiè N, Ghofrani H, Jansa P, Le Brun F-O, Mehta S, Perchenet L, Pulido T, Sastry B, Sitbon O, Souza R, Torbicki A, Rubin L. Effect of Macitentan on Long-term Outcomes in Patients With Pulmonary Arterial Hypertension (PAH): Subanalysis of SERAPHIN Comparing Incident and Prevalent Patient Populations Not Treated With Background PAH-Specific Therapy. Chest. Elsevier BV; 2013 Oct;144(4):876A-876A.
Published In
Chest
DOI
ISSN
0012-3692
Publication Date
October 2013
Volume
144
Issue
4
Start / End Page
876A / 876A
Publisher
Elsevier BV
Related Subject Headings
- Respiratory System
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences